Bioteque Financials
| 4107 Stock | TWD 126.00 1.50 1.18% |
Bioteque |
Understanding current and past Bioteque Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Bioteque's financial statements are interrelated, with each one affecting the others. For example, an increase in Bioteque's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Bioteque's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioteque. Check Bioteque's Beneish M Score to see the likelihood of Bioteque's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004107008 |
| Business Address | No 23 Chang-An |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.bioteq.com.tw |
| Phone | 886 2 2571 0269 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Bioteque without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Bioteque Stock, because this is throwing your money away. Analyzing the key information contained in Bioteque's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Bioteque Key Financial Ratios
There are many critical financial ratios that Bioteque's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bioteque reports annually and quarterly.| Return On Equity | 0.18 | |||
| Return On Asset | 0.0917 | |||
| Target Price | 138.0 | |||
| Number Of Employees | 12 | |||
| Beta | 0.57 |
Bioteque Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bioteque's current stock value. Our valuation model uses many indicators to compare Bioteque value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bioteque competition to find correlations between indicators driving Bioteque's intrinsic value. More Info.Bioteque is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bioteque is roughly 1.98 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bioteque's earnings, one of the primary drivers of an investment's value.Bioteque Systematic Risk
Bioteque's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Bioteque volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Bioteque correlated with the market. If Beta is less than 0 Bioteque generally moves in the opposite direction as compared to the market. If Bioteque Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Bioteque is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Bioteque is generally in the same direction as the market. If Beta > 1 Bioteque moves generally in the same direction as, but more than the movement of the benchmark.
Bioteque November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Bioteque help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bioteque. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bioteque based on widely used predictive technical indicators. In general, we focus on analyzing Bioteque Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bioteque's daily price indicators and compare them against related drivers.
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 5.16 | |||
| Value At Risk | (1.18) | |||
| Potential Upside | 1.1 |
Additional Tools for Bioteque Stock Analysis
When running Bioteque's price analysis, check to measure Bioteque's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioteque is operating at the current time. Most of Bioteque's value examination focuses on studying past and present price action to predict the probability of Bioteque's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioteque's price. Additionally, you may evaluate how the addition of Bioteque to your portfolios can decrease your overall portfolio volatility.